Preclinical studies of an S gene-deleted and trans-complemented SARS-CoV-2 as a novel intranasal booster for heterologous vaccination

View Statistics Email Alert RSS Feed

Grant Data
Project Title
Preclinical studies of an S gene-deleted and trans-complemented SARS-CoV-2 as a novel intranasal booster for heterologous vaccination
Principal Investigator
Professor Jin, Dong-Yan   (Principal Investigator (PI))
Co-Investigator(s)
Dr Cheung Pak Hin Hinson   (Co-Investigator)
Dr. Chan Pearl   (Co-Investigator)
Duration
36
Start Date
2024-07-01
Amount
1500000
Conference Title
Preclinical studies of an S gene-deleted and trans-complemented SARS-CoV-2 as a novel intranasal booster for heterologous vaccination
Keywords
COVID-19, SARS-CoV-2, Intranasal vaccination, Live attenuated vaccine, Booster vaccination
Discipline
Others - Medicine, Dentistry and Health
HKU Project Code
23220712
Grant Type
Health and Medical Research Fund 2022
Funding Year
2022
Status
On-going
Objectives
 To deliver an intranasal live-attenuated vaccine (LAV) candidate as a booster compatible with current COVID-19 vaccines.